Economic evaluation demonstrates cost-saving benefits of varicella vaccination in children, suggesting faster disease decline.
Our analyses suggest that inclusion of varicella vaccination in the national vaccination programme for children would be a cost-saving strategy from a societal perspective, which together with a catch-up vaccination offer for susceptible older children would result in a fast decline of varicella in Sweden.
No takes yet. Share an insight, caveat, or question.
Kasteng et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: